Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Ibrutinib enhances 41BB-costimulated CART19 function and persistence through immune reprogramming: Insights from the phase 3 ECOG-ACRIN E1912 clinical Trial
Ibrutinib enhances 41BB-costimulated CART19 function and persistence through immune reprogramming: Insights from the phase 3 ECOG-ACRIN E1912 clinical Trial Huynh, T., Wang, V., Feigin, J., Siegler, E., Kimball, B., Stewart, C., Yun, K., Mai, L., Roman, C., Xia, H., Sakemura, R., Can, I., Ruiz, O., Ogbodo, E., Sirpilla, O., Defranco, G., Goldberg, S., Saleh, A., Skeele, D., Foote, S., Yamaguchi, Y., Fonkoua, L., Torghabeh, M., Parikh, S., Pereira, V., Buckley, P., Ramsay, A., Shanafelt, T., Kay, N., Kenderian, S. ELSEVIER. 2025: 2101-2102View details for DOI 10.1182/blood-2025-2101
View details for Web of Science ID 001660246800001